Publication:
Effect of Rituximab in Patients with Relapsed or Refractory Primary Membranous Nephropathy

dc.contributor.authorAKYILDIZ, ARİF
dc.contributor.authorULUDAĞ, ÖMER
dc.contributor.authorMİRİOĞLU, ŞAFAK
dc.contributor.authorUÇAR, ALİ RIZA
dc.contributor.authorDEMİR, EROL
dc.contributor.authorÇALIŞKAN, YAŞAR KEREM
dc.contributor.authorÖZLÜK, MESUDE YASEMİN
dc.contributor.authorTÜRKMEN, AYDIN
dc.contributor.authorSEVER, MEHMET ŞÜKRÜ
dc.contributor.authorYAZICI, HALİL
dc.contributor.institutionauthorMİRİOĞLU, ŞAFAK
dc.date.accessioned2020-06-14T20:59:09Z
dc.date.available2020-06-14T20:59:09Z
dc.date.issued2020-06-06T00:00:00Z
dc.identifier.doi10.1093/ndt/gfaa142.p0353
dc.identifier.urihttps://hdl.handle.net/20.500.12645/18128
dc.identifier.yoksis6280981
dc.language.isoen
dc.subjectAKYILDIZ A., ULUDAĞ Ö., MİRİOĞLU Ş., UÇAR A. R. , DEMİR E., ÇALIŞKAN Y. K. , ÖZLÜK M. Y. , TÜRKMEN A., SEVER M. Ş. , YAZICI H., -Effect of Rituximab in Patients with Relapsed or Refractory Primary Membranous Nephropathy-, 57th ERA-EDTA Congress, 6 - 09 Haziran 2020, cilt.35, ss.657
dc.titleEffect of Rituximab in Patients with Relapsed or Refractory Primary Membranous Nephropathy
dc.typeConference Paper
dspace.entity.typePublication
local.avesis.id49b2111e-facc-4f3a-be15-d2b2157ab5dd
local.publication.isinternational1
relation.isAuthorOfPublication1a6fde04-64ba-4074-8a18-b696ffbbbd3e
relation.isAuthorOfPublication.latestForDiscovery1a6fde04-64ba-4074-8a18-b696ffbbbd3e
Files